Clinical trials
Completed Observational Multiple Sclerosis, Relapsing-Remitting trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
105 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2003 | 2 |
| 2005 | 5 |
| 2006 | 4 |
| 2007 | 4 |
| 2008 | 8 |
| 2009 | 9 |
| 2010 | 3 |
| 2011 | 3 |
| 2012 | 6 |
| 2013 | 4 |
| 2014 | 3 |
| 2015 | 6 |
| 2016 | 3 |
| 2017 | 8 |
| 2018 | 7 |
| 2019 | 2 |
| 2020 | 3 |
| 2021 | 14 |
| 2022 | 4 |
| 2023 | 5 |
| 2024 | 1 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 105 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Biogen | 17 |
| Merck KGaA, Darmstadt, Germany | 15 |
| Bayer | 10 |
| Novartis Pharmaceuticals | 5 |
| Bristol-Myers Squibb | 2 |
| Hikma Pharmaceuticals LLC | 2 |
| Kessler Foundation | 2 |
| McGill University | 2 |
| Novartis | 2 |
| Providence Health & Services | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Multiple Sclerosis, Relapsing-Remitting | 105 |
| Multiple Sclerosis | 54 |
| Multiple Sclerosis, Chronic Progressive | 16 |
| Fatigue | 3 |
| Demyelinating Diseases | 2 |
| Inflammation | 2 |
| Nerve Degeneration | 2 |
| Neurologic Manifestations | 2 |
| Arthritis, Rheumatoid | 1 |
| Autoimmune Diseases | 1 |
Trials
Showing 1 to 25 of 105. Each trial links to its page on Pharma Observatory.
5 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.